Literature DB >> 19500633

Corpus callosum size and shape alterations in individuals with bipolar disorder and their first-degree relatives.

Mark Walterfang1, Amanda G Wood, Sarah Barton, Dennis Velakoulis, Jian Chen, David C Reutens, Matthew J Kempton, Morgan Haldane, Christos Pantelis, Sophia Frangou.   

Abstract

Reductions in the size of the corpus callosum (CC) have been described in patients with bipolar disorder (BD), although the contribution of genetic factors to these changes is unclear. We previously showed a global thinning of the CC in BD patients, and found those with a family history of affective disorders had a larger CC than those without. In this study, we compared callosal size and shape in 180 individuals: 70 with BD, 45 of their first-degree relatives, and 75 healthy controls. The callosum was extracted from a mid-sagittal slice from T1-weighted magnetic resonance images, and its total area, length and curvature were compared across groups. A non-parametric permutation method was used to examine for alterations in width of the callosum along 39 points. Validating our previous findings, a significant global reduction in callosal thickness was seen in BD patients, with a disproportionate thinning in the anterior body. First-degree relatives did not differ in callosal size or shape from controls. In BD patients, duration of illness and age were associated with thinning in the anterior body; BD patients on lithium treatment showed a thicker anterior mid-body than those on other psychotropics. Global and regional thinning of the callosum is seen in BD but not in their first-degree relatives. This suggests that CC abnormalities are linked to disease expression in BD and may not represent a marker of familial predisposition.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19500633     DOI: 10.1016/j.pnpbp.2009.05.019

Source DB:  PubMed          Journal:  Prog Neuropsychopharmacol Biol Psychiatry        ISSN: 0278-5846            Impact factor:   5.067


  23 in total

1.  Dissociable and common deficits in inhibitory control in schizophrenia and bipolar disorder.

Authors:  Tessa Christodoulou; Lambros Messinis; Panagiotis Papathanasopoulos; Sophia Frangou
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2011-04-22       Impact factor: 5.270

2.  Corpus callosum area in patients with bipolar disorder with and without psychotic features: an international multicentre study.

Authors:  Samuel Sarrazin; Marc-Antoine d'Albis; Colm McDonald; Julia Linke; Michèle Wessa; Mary Phillips; Marine Delavest; Louise Emsell; Amelia Versace; Jorge Almeida; Jean-François Mangin; Cyril Poupon; Katia Le Dudal; Claire Daban; Nora Hamdani; Marion Leboyer; Josselin Houenou
Journal:  J Psychiatry Neurosci       Date:  2015-09       Impact factor: 6.186

3.  Psychoradiologic abnormalities of white matter in patients with bipolar disorder: diffusion tensor imaging studies using tract-based spatial statistics

Authors:  Cheng Yang; Lei Li; Xinyu Hu; Qiang Luo; Weihong Kuang; Su Lui; Xiaoqi Huang; Jing Dai; Manxi He; Graham J. Kemp; John A Sweeney; Qiyong Gong
Journal:  J Psychiatry Neurosci       Date:  2019-01-01       Impact factor: 6.186

Review 4.  Mapping vulnerability to bipolar disorder: a systematic review and meta-analysis of neuroimaging studies.

Authors:  Paolo Fusar-Poli; Oliver Howes; Andreas Bechdolf; Stefan Borgwardt
Journal:  J Psychiatry Neurosci       Date:  2012-05       Impact factor: 6.186

Review 5.  Neuroimaging Markers of Risk, Disease Expression, and Resilience to Bipolar Disorder.

Authors:  Sophia Frangou
Journal:  Curr Psychiatry Rep       Date:  2019-06-04       Impact factor: 5.285

6.  Investigating brain community structure abnormalities in bipolar disorder using path length associated community estimation.

Authors:  Johnson J Gadelkarim; Olusola Ajilore; Dan Schonfeld; Liang Zhan; Paul M Thompson; Jamie D Feusner; Anand Kumar; Lori L Altshuler; Alex D Leow
Journal:  Hum Brain Mapp       Date:  2013-06-25       Impact factor: 5.038

7.  Abnormal temporal lobe white matter as a biomarker for genetic risk of bipolar disorder.

Authors:  Katie Mahon; Katherine E Burdick; Toshikazu Ikuta; Raphael J Braga; Patricia Gruner; Anil K Malhotra; Philip R Szeszko
Journal:  Biol Psychiatry       Date:  2012-10-01       Impact factor: 13.382

8.  Towards person-centered neuroimaging markers for resilience and vulnerability in Bipolar Disorder.

Authors:  Sophia Frangou; Danai Dima; Jigar Jogia
Journal:  Neuroimage       Date:  2016-09-10       Impact factor: 6.556

9.  Neuroimaging in psychiatry: from bench to bedside.

Authors:  David E J Linden; Andreas J Fallgatter
Journal:  Front Hum Neurosci       Date:  2009-12-23       Impact factor: 3.169

Review 10.  A role for white matter abnormalities in the pathophysiology of bipolar disorder.

Authors:  Katie Mahon; Katherine E Burdick; Philip R Szeszko
Journal:  Neurosci Biobehav Rev       Date:  2009-11-06       Impact factor: 8.989

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.